EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer

Erin L. Milliken, Xiaoxue Zhang, Chris Flask, Jeffrey L. Duerk, Paul N. MacDonald, Ruth A. Keri

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences